Cargando…
Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy
The development of a safeguard system to remove tumorigenic cells would allow safer clinical applications of stem cells for the treatment of patients with an intractable disease including genetic disorders. Such safeguard systems should not disrupt the host genome and should have long-term stability...
Autores principales: | Uno, Narumi, Uno, Katsuhiro, Komoto, Shinya, Suzuki, Teruhiko, Hiratsuka, Masaharu, Osaki, Mitsuhiko, Kazuki, Yasuhiro, Oshimura, Mitsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014537/ https://www.ncbi.nlm.nih.gov/pubmed/26670279 http://dx.doi.org/10.1038/mtna.2015.45 |
Ejemplares similares
-
CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells
por: Uno, Narumi, et al.
Publicado: (2017) -
Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
por: Hiratsuka, Masaharu, et al.
Publicado: (2015) -
A luciferase complementation assay system using transferable mouse artificial chromosomes to monitor protein–protein interactions mediated by G protein-coupled receptors
por: Uno, Narumi, et al.
Publicado: (2018) -
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
por: Hiratsuka, Masaharu, et al.
Publicado: (2011) -
Panel of human cell lines with human/mouse artificial chromosomes
por: Uno, Narumi, et al.
Publicado: (2022)